Medicare Enrolled
Dr. Harshinder Singh, MD
Cardiovascular Disease · Brandon, FL
Practice pattern: Cardiac & Electrophysiology— Practice combining cardiac and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Singh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Singh? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Singh
Dr. Harshinder Singh is a cardiovascular disease in Brandon, FL, with 20 years in practice. Based on federal Medicare data, Dr. Singh performed 5,851 Medicare services across 4,084 unique beneficiaries.
Between the years covered by Open Payments, Dr. Singh received a total of $7,952 from 51 pharmaceutical and/or device companies across 402 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Singh is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 17% volume in FL$ $7,952 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,851
Medicare services
Top 17% in FL for cardiovascular disease
4,084
Unique beneficiaries
$88
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~293 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| EKG interpretation and report | 947 | $6 | $50 |
| Electrocardiogram (EKG), 12-lead | 738 | $10 | $42 |
| Office visit, established patient (30-39 min) | 683 | $90 | $260 |
| Injection, dipyridamole, per 10 mg | 403 | $3 | $18 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 369 | $350 | $792 |
| Office visit, established patient (20-29 min) | 309 | $68 | $129 |
| Echocardiogram, transthoracic | 298 | $137 | $405 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 250 | $48 | $216 |
| Regadenoson injection (Lexiscan) for heart stress test | 248 | $38 | $130 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 193 | $330 | $722 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 155 | $28 | $60 |
| Hospital follow-up visit, high complexity | 116 | $94 | $200 |
| New patient office visit (45-59 min) | 111 | $119 | $339 |
| Ultrasound study of arm and leg arteries | 100 | $51 | $236 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 97 | $20 | $100 |
| Heart rhythm recording, analysis, interpretation and report of continous external ekg over more than 1 week up to 1 weeks | 93 | $196 | $350 |
| Remote pacemaker/defibrillator monitoring, 90 days | 73 | $16 | $67 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 73 | $134 | $368 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 66 | $20 | $54 |
| Remote pacemaker monitoring, 90 days | 54 | $23 | $72 |
| Injection, aminophyllin, up to 250 mg | 54 | $7 | $15 |
| Ultrasound of both sides of head and neck blood flow | 51 | $135 | $468 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 44 | $84 | $340 |
| Initial hospital admission, high complexity | 42 | $134 | $389 |
| Transitional care management services for problem of high complexity | 41 | $209 | $490 |
| Hospital follow-up visit, moderate complexity | 39 | $63 | $139 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 27 | $10 | $25 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring and review and report by health care professional | 26 | $125 | $600 |
| Programming of dual lead pacemaker system | 22 | $61 | $126 |
| Transitional care management services for problem of at least moderate complexity | 21 | $151 | $370 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 18 | $27 | $152 |
| Cardiac catheterization | 17 | $207 | $692 |
| Insertion of heart rhythm monitor under skin | 16 | $3,267 | $9,779 |
| Ultrasonic guidance for blood vessel access | 16 | $12 | $28 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 15 | $201 | $570 |
| Evaluation of implantable heart and blood vessel monitoring system | 14 | $35 | $100 |
| Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 12 | $189 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.2% high complexity
23.7% medium
68.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,952
Total received (2018-2024)
Avg $1,136/year across 7 years
Top 29% in FL for cardiovascular disease
51
Companies
402
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,765 (97.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$160 (2.0%)
Scientific / Research
Research funding and grants
$27 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,569
2023$1,348
2022$830
2021$1,363
2020$818
2019$823
2018$1,200
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,053
Novartis Pharmaceuticals Corporation
$575
Abbott Laboratories
$573
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$409
Boehringer Ingelheim Pharmaceuticals, Inc.
$381
Philips North America LLC
$378
Medtronic Vascular, Inc.
$325
E.R. Squibb & Sons, L.L.C.
$323
Amarin Pharma Inc.
$308
PFIZER INC.
$307
Astellas Pharma US Inc
$292
Janssen Pharmaceuticals, Inc
$253
Amgen Inc.
$252
AngioDynamics, Inc.
$248
Kestra Medical Technology Services, Inc.
$199
Merck Sharp & Dohme LLC
$179
Philips Electronics North America Corporation
$172
Medtronic, Inc.
$168
Boston Scientific Corporation
$145
Bayer Healthcare Pharmaceuticals Inc.
$105
Impulse Dynamics (USA) Inc.
$100
SANOFI-AVENTIS U.S. LLC
$99
Preventice Services, LLC
$90
Novo Nordisk Inc
$88
Esperion Therapeutics, Inc.
$86
Cardiovascular Systems Inc.
$73
Bayer HealthCare Pharmaceuticals Inc.
$70
ATRICURE, INC.
$59
Kiniksa Pharmaceuticals, Ltd.
$55
Gilead Sciences, Inc.
$52
CVRx, Inc.
$48
BOSTON SCIENTIFIC CORPORATION
$45
iRhythm Technologies, Inc.
$44
Edwards Lifesciences Corporation
$40
MEDICOMP INC
$33
United Therapeutics Corporation
$33
Merck Sharp & Dohme Corporation
$31
Cook Medical LLC
$27
BAXTER HEALTHCARE
$26
Lexicon Pharmaceuticals, Inc.
$21
Kowa Pharmaceuticals America, Inc.
$21
Vital Connect, Inc
$21
Lundbeck LLC
$20
Bardy Diagnostics, Inc.
$20
CMS Imaging, Inc.
$18
Regeneron Healthcare Solutions, Inc.
$18
Aziyo Biologics, Inc.
$16
EKOS Corporation
$16
BIOTRONIK INC.
$13
Bard Peripheral Vascular, Inc.
$12
W. L. Gore & Associates, Inc.
$12
Top 3 companies account for 27.7% of total payments
Associated products mentioned in payments ›
(5044) MCOT · (5050) Ext Holter · (5050) Extended Holter · (7999) SRC Undivided · (CK4) MCOT · (CK7) Extended Holter · ACCENT · AVEIR · Acticor · Arcalyst · Assure WCD · Assurity Pacemaker · Auryon Laser System 100-120 Vac · Azure · BG Mini Plus · BRILINTA · Barostim Neo System · CAMZYOS · CARDIOMEMS · CHANTIX · CONFIRM RX · Cardiac Monitor · CardioMEMS HF System · CareLink · Carnation Ambulatory Monitor · Claria MRI · Confirm Rx · Corlanor · Coronary Orbital Atherectomy System · Diamondback Coronary · ECM Patch · EKOSONIC · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edwards SAPIEN 3 Transcatheter Heart Valve · FARXIGA · FLOSEAL · General - Therapies · General - Vascular Access · Inpefa · JARDIANCE · JOT DX · Kerendia · LEQVIO · LEXISCAN · LINQ II · LUX-Dx Insertable Cardiac Monitor · Lexiscan · LifeVest · Livalo · MITRACLIP · MULTAQ · Merlin Connectivity and Remote · Micra · Mitra Clip system · MitraClip System · NEXLETOL · NORTHERA · OPTIMIZER · Optimizer · Optis Coronary Imaging System · Ozempic · PRADAXA · PRALUENT · PULSESELECT · Peripheral Orbital Atherectomy System · Pouch · Quadra Assura CRT Defibrillator · Repatha · Reveal LINQ · Rybelsus · TYVASO · VERQUVO · VIABAHN VBX Balloon Expandable Endoprosthesis · VITALPATCH RTM · VYNDAQEL · Vascepa · WAINUA · WATCHMAN · WATCHMAN Access System · XARELTO · XIENCE SIERRA · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $136 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
174
Per 100K population
11.7
County median income
$75,011
Nearest hospital
HCA FLORIDA BRANDON HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Singh is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 17% in FL), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Singh experienced with ekg interpretation and report?
Based on Medicare claims data, Dr. Singh performed 947 ekg interpretation and report services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Singh receive payments from pharmaceutical companies?
Yes. Dr. Singh received a total of $7,952 from 51 companies across 402 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Singh's costs compare to other cardiovascular diseases in Brandon?
Dr. Singh's average Medicare payment per service is $88. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Singh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Brandon
Browse cardiovascular diseases in Brandon ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology